- Title
- Comparative effectiveness of Anti‐IL5 and Anti‐IgE biologic classes in patients with severe asthma eligible for both
- Creators - without role
- Paul Pfeffer - Barts Health NHS TrustNasloon Ali - Observational & Pragmatic Research InstituteRuth MurrayCharlotte Ulrik - Copenhagen University HospitalTrung Tran - AstraZenecaJorge Maspero - Favaloro FoundationMatthew Peters - Concord Repatriation General HospitalGeorge Christoff - Medical University of SofiaMohsen Sadatsafavi - University of British ColumbiaCarlos Torres-Duque - Fundación Neumológica ColombianaAlan Altraja - Tartu University HospitalLauri Lehtimäki - Tampere UniversityNikolaos Papadopoulos - National and Kapodistrian University of AthensSundeep SalviRichard Costello - Beaumont HospitalBreda Cushen - Beaumont HospitalEnrico Heffler - Humanitas UniversityTakashi Iwanaga - Kindai University HospitalMona Al-Ahmad - Kuwait UniversityDésirée Larenas-Linnemann - Hospital Médica SurPiotr Kuna - Medical University of LodzJoão Fonseca - Universidade do PortoRiyad Al-Lehebi - Alfaisal UniversityChin Kook Rhee - Catholic University of KoreaLuis Perez-De-LlanoDiahn‐warng Perng SteveBassam Mahboub - University of SharjahEileen Wang - National Jewish HealthCeline Goh - Observational & Pragmatic Research InstituteJuntao Lyu - Observational & Pragmatic Research InstituteAnthony Newell - Observational & Pragmatic Research InstituteMarianna AlacquaAndrey BelevskiyMohit Bhutani - University of AlbertaLeif Bjermer - Skåne University HospitalUnnur Bjornsdottir - Reykjavík UniversityArnaud Bourdin - Université de Montpellier, Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExpAnna von Bulow - Bispebjerg HospitalJohn Busby - Queen's University BelfastGiorgio Walter Canonica - Humanitas UniversityBorja Cosio - Health Research Institute of the Balearic IslandsDel DorscheidMariana Muñoz-Esquerre - Bellvitge University HospitalJ. Mark Fitzgerald - University of British ColumbiaEsther Garcia Gil - AstraZenecaPeter Gibson - Hunter Medical Research InstituteLiam Heaney - Queen's University BelfastMark Hew - Alfred HealthOle Hilberg - Vejle SygehusFlavia Hoyte - National Jewish HealthDavid Jackson - King's College LondonMariko Siyue Koh - Singapore General HospitalHsin‐kuo Ko BruceJae Ha Lee - Inje University Haeundae Paik HospitalSverre Lehmann - Haukeland University HospitalCláudia Chaves LoureiroDóra Lúðvíksdóttir - Reykjavík UniversityAndrew Menzies-Gow - Harefield HospitalPatrick Mitchell - Trinity College DublinAndriana Papaioannou - National and Kapodistrian University of AthensTodor Popov - University Hospital St. Ivan RilskiCeleste Porsbjerg - Bispebjerg HospitalLaila Salameh - University of SharjahConcetta SirenaCamille Taillé - Université Paris CitéChristian Taube - RuhrlandklinikYuji Tohda - Kindai University HospitalMichael Wechsler - University of Colorado DenverDavid Price - University of Aberdeen
- Publication Details
- Allergy, Vol.78(7), pp.1934-1948
- Identifiers
- 9942653409311
- Academic Unit
- Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
- Language
- English
- Resource Type
- Journal article
- Local Fields
- hal-04039334
Journal article
Comparative effectiveness of Anti‐IL5 and Anti‐IgE biologic classes in patients with severe asthma eligible for both
Allergy, Vol.78(7), pp.1934-1948
2023
Metrics
1 Record Views